Patrick Glassman

Assistant Professor of Pharmaceutical Sciences at Temple University

[Patrick Glassman @GlassmanLab]

Happy to share that I will be presenting in the @APVnews online seminar on Latest Advances in R&D for LNPs for RNA Drug Delivery, which will be held on January 29, 2026!

More details at the following link: https://t.co/aalYedfu0z

[ASPET @ASPET]

Congrats to the 4 recipients of Trainee Challenge Awards, awarded through a partnership with ASPET and @PhRMAfoundation, recognized for their work in rapidly emerging areas in drug discovery research. Their award-winning research is free to read and share: https://t.co/HlzyPj39wa

[Patrick Glassman @GlassmanLab]

Happy to share our latest review, led by @kishore13_16 and published in @JPET_Journal, which focuses on half-life extension of peptide and protein therapeutics!

https://t.co/eSQSzuoPVR

[Patrick Glassman @GlassmanLab]

Happy to share the latest review article from our group published in @Cancers_MDPI, which focuses on PK/PD modeling strategies for antibody-drug conjugates. https://t.co/nILwMx0Ft8

[Patrick Glassman @GlassmanLab]

Congrats to Glassman lab undergraduate student Ria Singh on her poster presentation at the Temple CST Undergraduate Research Symposium!

[ASPET @ASPET]

Applications to become a 2026 ASPET Editorial Fellow are now open! Those chosen for the program will have an opportunity to learn important elements of the editorial process. The deadline for applications is November 17. Learn more and apply: https://t.co/dDSe8OmqWl

[Patrick Glassman @GlassmanLab]

Getting ready to travel to Aurora, CO to attend ACoP 2025! I'll be co-teaching a post-conference workshop with @lab_rao and @SharifSoleman on PBPK modeling to support drug development!

[Patrick Glassman @GlassmanLab]

New publication in collaboration with @PennMedicine, @PennEngineers , and @AcuitasTx in @PNASNews ! Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo | PNAS https://t.co/l4M45kS7pn

[Patrick Glassman @GlassmanLab]

@LindsayCzuba Thanks Lindsay!

[Patrick Glassman @GlassmanLab]

Excited to be a part of this really talented team and contribute our expertise to characterize PK/PD of live biotherapeutics!

[Juliane Nguyen @JulieNguyenLab]

We're incredibly grateful to the #NIH for supporting our research with a $3 million 4-year R01 grant to develop targeted probiotic yeast therapies for inflammatory bowel diseases.
@DPMP_UNC @UNCPharmacy

[Patrick Glassman @GlassmanLab]

We are now accepting applications for our online Graduate Certificate in PK and Mechanistic Modeling, which launches in Fall 2025! Please reach out with any questions!

https://t.co/27uOtoojwj

[Patrick Glassman @GlassmanLab]

In addition, our PY2 student Manali Patel was selected as the top PharmD student abstract and gave an oral presentation on her work on half-life extended anti-thrombotics!

[Patrick Glassman @GlassmanLab]

Last Friday was @TU_SP Research Recognition Day and our group had four poster presentations by PharmD and PhD students!

[Patrick Glassman @GlassmanLab]

Please reach out if you are interested in submitting a primary research article or minireview to this issue - especially if you have a trainee that would be interested in the Challenge Award! @JPET_Journal @ASPET

[JPET (ASPET) @JPET_Journal]

ASPET’s JPET and @PhRMAFoundation are partnering on a Challenge Award competition—a prize of $5,000—to the first author of up to five winning papers! Submit your papers on the #pharmacology of next generation therapeutics by July 1, 2025.

🔗Learn more: https://t.co/gOqOQKurbd

[JPET (ASPET) @JPET_Journal]

ASPET’s JPET and @PhRMAFoundation are partnering on a Challenge Award competition—a prize of $5,000—to the first author of up to five winning papers! Submit your papers on the #pharmacology of next generation therapeutics by July 1, 2025.

🔗Learn more: https://t.co/gOqOQKurbd

[Patrick Glassman @GlassmanLab]

I'm happy to share our latest publication in @BioconjChem describing the use of RBCs as carriers to prolong the circulation time of Factor IX! https://t.co/Oa6VvgGsX9

[JPET (ASPET) @JPET_Journal]

ASPET’s JPET and @PhRMAFoundation are partnering on a Challenge Award competition—a prize of $5,000—to the first author of up to five winning papers! Submit your papers on the #pharmacology of next generation therapeutics by July 1, 2025.

🔗Learn more: https://t.co/gOqOQKurbd

[Patrick Glassman @GlassmanLab]

Happy to share information about a special issue of @JPET_Journal that I am co-editing with @JulieNguyenLab entitled Pharmacology of Next Generation Therapeutics. We've partnered with @PhRMAfoundation, who is sponsoring a Trainee Challenge Award!
https://t.co/Sb5JjsCtls

[ASPET @ASPET]

ASPET’s Editorial Fellowship Program is accepting applications for its 2025 class. Fellows will learn important elements of the editorial process, including all aspects of the submission process, peer review, and editorial decisions. Apply by Dec 11: https://t.co/3iELI0oPEh.

[JPET (ASPET) @JPET_Journal]

ASPET’s Editorial Fellowship Program is accepting applications for its 2025 class. Fellows will learn important elements of the editorial process, including all aspects of the submission process, peer review, and editorial decisions. Apply by Dec 11: https://t.co/OHMYpjZKop.